Hair Loss and Zinc Deficiency: A Cross-Sectional Study.
Study Design
- Loại nghiên cứu
- Retrospective Cross-Sectional Study
- Cỡ mẫu
- 23975
- Can thiệp
- Hair Loss and Zinc Deficiency: A Cross-Sectional Study. None
- Đối chứng
- Placebo
- Xu hướng hiệu quả
- Neutral
- Nguy cơ sai lệch
- Moderate
Abstract
Background: Hair loss is a common complaint, especially in the primary care setting. Despite conflicting results in previous studies regarding the role of zinc in hair loss, zinc levels are being widely tested as part of an initial laboratory investigation for hair loss. Objectives: We aimed to investigate whether lower zinc levels were associated with patients' complaints of hair loss. Methods: In this retrospective cross-sectional study, we collected data on the zinc levels of patients diagnosed with hair loss who underwent a zinc level test after their diagnosis. The zinc levels of these patients were compared to those of a control group, which included patients who were also investigated for zinc levels for reasons other than hair loss. Results: Between 2000 and 2020, 23,975 eligible patients were included in this study. Among these patients, 9.5% (N = 2279) had a diagnosis of hair loss and a median zinc level of 96 µg/dL (84.0-110.0), compared to 99 µg/dL (85.0-115.0) in the control group (p < 0.001). Conclusions: This cross-sectional study investigated the relationship between zinc levels and complaints of hair loss. While we do report lower zinc levels in those with hair loss complaints, this change is minor and lacks clinical significance. As the standard today, we suggest that zinc levels should not be obtained as a laboratory test when investigating hair loss. Further studies on the efficacy of zinc supplements in hair loss could elucidate the clinical relevance of zinc in hair loss conditions.
Full Text
Tables
Table 4
| Effect Size | Zinc, Median [IQR] | Zinc Levels, Median [IQR] | |||
|---|---|---|---|---|---|
| 65+ | 18–64 | Age (at the first zinc test) | |||
| 0.02 | 0.008 | 100.0 [86.0–116.0] | 98.0 [85.0–114.0] | ||
| Women | Men | Sex | |||
| 0.05 | <0.001 | 98.0 [85.0–113.0] | 102.0 [84.0–120.0] | ||
| High (8–10) | Medium (5–7) | Low (1–4) | SES | ||
| 0.003 | 0.000 | 100.0 [86.0–115.0] | 98.0 [84.0–113.0] | 96.0 [81.0–113.0] | |
| If absent | If present (Median [IQR]) | Health-related Variables | |||
| 0.02 | <0.001 | 99.0 [85.0–114.0] | 97.0 [83.0–114.0] | Smoking | |
| 0.02 | <0.001 | 98.0 [85.0–114.0] | 101.0 [85.0–118.0] | Cancer | |
| 0.03 | <0.001 | 98.0 [85.0–114.0] | 104.0 [89.0–119.0] | Diabetes | |
| 0.01 | 0.164 | 98.0 [85.0–114.0] | 99.0 [85.0–116.0] | Hypertension | |
| 0.002 | 0.716 | 98.0 [85.0–114.0] | 98.0 [85.0–115.0] | Cardiovascular disease | |
| 0.002 | 0.980 | 98.0 [85.0–114.0] | 98.0 [86.0–112.0] | Lung disease | |
| 0.001 | 0.092 | 98.0 [85.0–114.0] | 98.0 [85.0–110.0] | Chronic kidney disease | |
Table 5
| MHS | Maccabi Healthcare Services |
| HMO | Health Maintenance Organization |
| HIV | human immunodeficiency virus |
| SES | socioeconomic status |
| TSH | Thyroid-Stimulating Hormone |
References
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
Used In Evidence Reviews
Similar Papers
Nature · 2010
Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.
Journal of the American Academy of Dermatology · 2006
The diagnosis and treatment of iron deficiency and its potential relationship to hair loss.
Clinical and experimental dermatology · 1989
Juvenile versus maturity-onset alopecia areata--a comparative retrospective clinical study.
American journal of clinical dermatology · 2005
Dermatologic signs in patients with eating disorders.
Archives of biochemistry and biophysics · 2016
Zinc and skin biology.
Annals of dermatology · 2013